Addressing the risk of ocular complications of <scp>GLP</scp> ‐ <scp>1RAs</scp> ; a multi‐disciplinary expert consensus
Further research is needed into the direct effects of GLP-1RAs on the retina and ocular complications. New evidence should be disseminated rapidly to optimise outcomes and safety.
Authors
- Philip I. Burgess (ORCID: https://orcid.org/0000-0002-3959-2299)
- Sarah J. Davies (ORCID: https://orcid.org/0000-0002-0994-0440)
- Ian Pearce (ORCID: https://orcid.org/0000-0002-7710-0531)
- W. David Strain (ORCID: https://orcid.org/0000-0002-6826-418X)
- Monica Lövestam‐Adrian (ORCID: https://orcid.org/0000-0002-5675-6590)
- Marc Evans (ORCID: https://orcid.org/0000-0003-0671-0778)
- Amy Gamble
- Christiana Dinah (ORCID: https://orcid.org/0000-0002-0815-4771)
- Stephen C. Bain (ORCID: https://orcid.org/0000-0001-8519-4964)
- Patrice Carter (ORCID: https://orcid.org/0000-0003-3445-6754)
- Rafael Simó (ORCID: https://orcid.org/0000-0003-0475-3096)
- Chloe Hembury
Institutions
- University of Liverpool (GB)
- Lund University (SE)
- University of Exeter (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- London North West Healthcare NHS Trust (GB)
- Swansea University (GB)
- Vall d'Hebron Institut de Recerca (ES)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- University Hospital Llandough (GB)
- Woodlands Hospital (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1111/dom.70160
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71